Rice Bran Compound Eases Intestinal Contractions
Ferulic acid, a compound found in rice bran, shows promise in easing intestinal contractions for those suffering from irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Research indicates that ferulic acid inhibits smooth muscle contractions. This finding from the Journal of pharmacological Sciences suggests a new approach to managing intestinal motility disorders.The study investigated the effects of the primarykeyword to address the secondarykeyword,potentially offering relief,particularly for diarrhea-predominant conditions. The research, conducted on guinea pig models, warrants further examination into dietary interventions. News Directory 3 is following this story. Though, researchers caution that ferulic acid might worsen symptoms in constipation-predominant cases. Clinical trials are needed to solidify these findings and find suitable dosage levels.Discover what’s next in gut health research.
Rice Bran Compound May Offer Relief for IBS, IBD Sufferers
Ferulic acid (FA), a compound prevalent in rice bran and other whole grains, may offer a new dietary approach to managing intestinal motility disorders, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). According to a study published in the Journal of Pharmacological Sciences, FA suppresses intestinal smooth muscle contractions by inhibiting voltage-dependent calcium channels.
Led by Dr. Siusuke Obara, Dr. Kento Yosike, and Professor Yosiso Tanaka from the Faculty of Pharmaceutical Sciences at Toho University, the research team explored FA’s impact on gastrointestinal motility, an area previously unclear despite FA’s known antioxidant and neuroprotective properties.
In individuals with IBS and IBD, abnormal intestinal movements are common.The study investigated whether FA could influence these contractions. Experiments on guinea pig ileal longitudinal smooth muscle (ILSM) revealed that FA considerably inhibited contractions induced by neurotransmitters like acetylcholine, histamine, prostaglandin F2a, and serotonin. These effects were noncompetitive and concentration-dependent.
Further tests using vascular smooth muscle cell models showed that FA reduced intracellular calcium elevation caused by potassium chloride, indicating its effect on voltage-dependent calcium channels.
The findings suggest that ferulic acid could serve as a natural modulator of intestinal motility,potentially alleviating diarrhea-predominant IBD by calming excessive smooth muscle activity. Though, researchers cautioned that in individuals with constipation-predominant IBS, FA might worsen symptoms by overly suppressing motility.
The team noted that the FA concentrations effective in vitro were higher than typical blood levels achieved through diet. They suggest that because intestinal concentrations may be higher after oral intake, further studies are needed to assess the physiological relevance and potential clinical applications of ferulic acid.
The research provides a basis for further investigation into dietary interventions or supplements targeting gut motility using ferulic acid. Clinical trials are necessary to confirm these effects in humans and determine appropriate intake levels for therapeutic efficacy in treating IBS and IBD.